European Union withdraws with counter tariffs on US goods
The European Union is imposing anti -income in response to President Donald Trump’s steel and aluminum rates.
WASHINGTON – Increasing the trade war with Europe, President Donald Trump said on Wednesday that the United States would fight the European Union’s retaliation, which will be on US exports announced earlier in the day.
“Of course I will respond to this,” I will respond to this. “Look, the European Union was established to take advantage of the United States.”
While meeting with Ireland’s Prime Minister Michael Martin at the Oval Office, Trump poses the threat. Trump said Ireland is one of the European Union countries taking advantage of the United States, and that US pharmaceutical companies have moved to Ireland.
“Look, Irish are smart. You have smart people, “Trump said, turning to Martin.” And you took our pharmaceutical companies and other companies through taxing. They made the companies great to move there.
The aggressive use of Trump’s prices, including 25 % duties on many of the goods imported from neighboring Canada and Mexico, has shaken the stock market and has stopped consumer problems over rising costs.
Trump did not clearly indicate which European Union products could be targeted by additional taxes, which he says is needed to rebuild domestic manufacturing in key industries. But in his meeting with the Irish leader, Trump repeatedly talked about pharmaceutical imports, a area that he had promised to target prices.
“When pharmaceutical companies started going to Ireland, I said, if you want to go to Ireland, that’s fine, I think it’s great.” “But if you want to sell anything in the United States, I will put 200 % tariff on you. So you will never be able to sell anything in the United States. You know what they do. They lived here.”
Earlier, Trump has promised 25 % of the revenue on imports from the European Union as part of the new bilateral revenue, which is set to take place on April 2, under which the United States will respond to any country’s revenue imposed on US exports, matching the same rates of the same rates.
Trump reiterated his plans on Wednesday, “Whatever it is, it doesn’t matter what it is.” “If they receive 25 % or 20 %, or 10 % or 2 % or 200 %, then we are charging them. I don’t know why people get upset about it because there is nothing more appropriate.”
Pharmaceutical research and US manufacturersThe leading lobbying group of the pharmaceutical industry said in a statement that the biofarmastical industry is already one of the top manufacturers in the United States and noted that several companies have announced plans to build new US manufacturing facilities.
“Medicinal revenue will make companies difficult to invest more in the United States,” said Megan Wan Eaton, Vice President of Public Affairs for PHRMA. We believe that alternative trade measures should be used to eliminate unfair methods abroad in the United States, while reducing the rules and costs for construction in the United States.
X @ @ @ @ @ @ @ @ @ @ @ Joi arrive at the garrison.
